Team:Queens Canada/Safety/Lab
From 2011.igem.org
Line 16: | Line 16: | ||
<div id="rightcontenttext"> <p><p> | <div id="rightcontenttext"> <p><p> | ||
- | < | + | <h3green>Safety Proposal</h3green> <p> |
<regulartext> | <regulartext> | ||
We feel confident that our project does not pose a risk to ourselves, to the public, or to the environment. <i>C. elegans</i>, our chassis, is not a human pathogen. Working with <i>C. elegans</i> carries very little risk to researchers, and BSL-1 level laboratory clearance is satisfactory for work with this organism. Furthermore, microinjection of extrachromosomal arrays reduces the worm’s fitness. So, if a transgenic worm were to escape into the outside environment, it would be unlikely to have a selective advantage over wild-type worms. As well, our biobricks do not provide the worm with any selective advantages. In fact, they may reduce fitness by forcing the worm to chemotax toward naphthalene, a toxic chemical. In addition, there are a number of germline mortal <i>C. elegans mutants</i>. If our transgenic worm were to be used in the field, we would ensure that it contained a germline mortal mutation.</regulartext> | We feel confident that our project does not pose a risk to ourselves, to the public, or to the environment. <i>C. elegans</i>, our chassis, is not a human pathogen. Working with <i>C. elegans</i> carries very little risk to researchers, and BSL-1 level laboratory clearance is satisfactory for work with this organism. Furthermore, microinjection of extrachromosomal arrays reduces the worm’s fitness. So, if a transgenic worm were to escape into the outside environment, it would be unlikely to have a selective advantage over wild-type worms. As well, our biobricks do not provide the worm with any selective advantages. In fact, they may reduce fitness by forcing the worm to chemotax toward naphthalene, a toxic chemical. In addition, there are a number of germline mortal <i>C. elegans mutants</i>. If our transgenic worm were to be used in the field, we would ensure that it contained a germline mortal mutation.</regulartext> |
Revision as of 18:34, 28 September 2011